Unknown

Dataset Information

0

Disease progression in systemic sclerosis.

ABSTRACT:

SUBMITTER: van Leeuwen NM 

PROVIDER: S-EPMC7937017 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis.
| S-EPMC7691442 | biostudies-literature
Unknown Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.
| S-EPMC8238790 | biostudies-literature
Unknown Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease.
| S-EPMC10224939 | biostudies-literature
Unknown Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis.
| S-EPMC11534140 | biostudies-literature
Unknown Gastrointestinal symptom severity and progression in systemic sclerosis.
| S-EPMC9789747 | biostudies-literature
Unknown Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis-Interstitial Lung Disease: A Systematic Review.
| S-EPMC8829727 | biostudies-literature
Unknown The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.
| S-EPMC7584725 | biostudies-literature
Unknown Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease.
| S-EPMC11381690 | biostudies-literature
Unknown Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression.
| S-EPMC10072882 | biostudies-literature
Unknown An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung disease.
| S-EPMC10585397 | biostudies-literature